Effects of ossein-hydroxyapatite compound on ewe bone remodeling: biochemical and histomorphometric study
- PMID: 1665111
- DOI: 10.1007/BF02208688
Effects of ossein-hydroxyapatite compound on ewe bone remodeling: biochemical and histomorphometric study
Abstract
Ossein-hydroxyapatite compound (OHC) is a protein-mineral complex derived from bovine bone. Its effects on bone remodeling were studied in old ewes which have seasonal variations in bone remodeling. Seven animals received 200 mg OHC/kg b.w./day for 90 days from July to September. The control group consisted of 7 untreated animals followed for the same period of time. OHC was administered through a fistula into the fourth stomach. A significant decrease of bone histomorphometric parameter values was noted in controls at the end of the experiment, due to seasonal variations: the cancellous eroded perimeter decreased by 45%, the osteoblastic perimeter by 60% and the bone formation rate at the cell level by 20%. In contrast, in the treated-group, these parameters tended to increase or did not change. In conclusion, counteracting the significant seasonal reduction of bone remodeling in ewes, OHC seems able to stimulate directly or indirectly bone metabolism, especially when osteoblast activity is reduced and may partly prevent the seasonal reduction of bone turnover.
Similar articles
-
Dose effects on ewe bone remodeling of short-term sodium fluoride administration--a histomorphometric and biochemical study.Bone. 1991;12(6):421-7. doi: 10.1016/8756-3282(91)90031-d. Bone. 1991. PMID: 1797057
-
Effects of a new selective estrogen receptor modulator (MDL 103,323) on cancellous and cortical bone in ovariectomized ewes: a biochemical, histomorphometric, and densitometric study.J Bone Miner Res. 2001 Jan;16(1):89-96. doi: 10.1359/jbmr.2001.16.1.89. J Bone Miner Res. 2001. PMID: 11149494
-
Examination of new bone growth on aluminium oxide implant contact surfaces after oral administration of ossein-hydroxyapatite compound to rats.Curr Med Res Opin. 1988;11(2):107-15. doi: 10.1185/03007998809110453. Curr Med Res Opin. 1988. PMID: 2851412
-
Use of ossein-hydroxyapatite complex in the prevention of bone loss: a review.Climacteric. 2015 Feb;18(1):29-37. doi: 10.3109/13697137.2014.929107. Epub 2014 Aug 17. Climacteric. 2015. PMID: 24893923 Review.
-
The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.APMIS Suppl. 2001;(102):1-52. APMIS Suppl. 2001. PMID: 11419022 Review.
Cited by
-
Prevention of osteoporosis: four-year follow-up of a cohort of postmenopausal women treated with an ossein-hydroxyapatite compound.Clin Drug Investig. 2007;27(4):227-32. doi: 10.2165/00044011-200727040-00001. Clin Drug Investig. 2007. PMID: 17358094
-
Comparison of the effects of ossein-hydroxyapatite complex and calcium carbonate on bone metabolism in women with senile osteoporosis: a randomized, open-label, parallel-group, controlled, prospective study.Clin Drug Investig. 2011 Dec 1;31(12):817-24. doi: 10.1007/BF03256920. Clin Drug Investig. 2011. PMID: 22035462 Clinical Trial.